Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Feb-24 9:51 PM View:  | Kalvista Pharmaceuticals, I... (KALV) | 20-Feb-24 | Option Sale | 8,397 | $14.11 | $118,522.00 | (9%) 90.44K to 82.05K | |
| 21-Feb-24 9:51 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 20-Feb-24 | Planned Option Sale | 10,391 | $14.05 | $145,961.00 | (13%) 82.05K to 71.66K | |
| 21-Feb-24 9:51 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 20-Feb-24 | Sale (Planned) | 9,500 | $14.05 | $133,446.00 | (13%) 71.66K to 62.16K | |
| 21-Feb-24 9:51 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Feb-24 | Option Exercise | 18,788 | -- | -- | 26% 71.66K to 90.44K | |
| 16-Feb-24 4:19 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 14-Feb-24 | Private Sale | 28,171 | $15.01 | $422,827.00 | (28%) 99.83K to 71.66K | |
| 13-Feb-24 9:20 AM View: | Kalvista Pharmaceuticals, I... (KALV) | 11-Feb-24 | Grant | 60,000 | -- | -- | 151% 39.83K to 99.83K | |
| 12-Jan-24 4:26 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 11-Jan-24 | Market Sale (Planned) | 22,679 | $13.03 | $295,514.00 | (36%) 62.51K to 39.83K | < 1% |
| 10-Jan-24 6:05 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 09-Jan-24 | Market Sale (Planned) | 100 | $13.00 | $1,300.00 | (< 1%) 62.61K to 62.51K | < 1% |
| 10-Jan-24 6:05 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 08-Jan-24 | Market Sale (Planned) | 17,221 | $13.01 | $224,000.00 | (22%) 79.83K to 62.61K | < 1% |
| 21-Nov-23 4:33 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 20-Nov-23 | Option Sale | 4,958 | $8.23 | $40,800.90 | (6%) 84.79K to 79.83K | |
| 21-Nov-23 4:33 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Nov-23 | Option Exercise | 11,497 | -- | -- | 16% 73.29K to 84.79K | |
| 21-Aug-23 10:00 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 18-Aug-23 | Option Sale | 4,976 | $10.73 | $53,386.00 | (6%) 78.27K to 73.29K | |
| 21-Aug-23 10:00 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Aug-23 | Option Exercise | 11,494 | -- | -- | 17% 66.77K to 78.27K | |
| 19-May-23 9:18 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 18-May-23 | Option Sale | 1,786 | $10.14 | $18,117.90 | (3%) 68.56K to 66.77K | |
| 19-May-23 9:18 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-May-23 | Option Exercise | 4,205 | -- | -- | 7% 64.35K to 68.56K | |
| 23-Feb-23 5:44 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Feb-23 | Option Exercise | 4,204 | -- | -- | 7% 62.38K to 66.58K | |
| 23-Feb-23 5:44 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Feb-23 | Option Sale | 2,228 | $7.66 | $17,066.50 | (3%) 66.58K to 64.35K | |
| 21-Nov-22 4:18 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 18-Nov-22 | Option Sale | 530 | $5.44 | $2,883.20 | (< 1%) 62.91K to 62.38K | |
| 21-Nov-22 4:18 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Nov-22 | Option Exercise | 1,774 | -- | -- | 3% 61.13K to 62.91K | |
| 19-Aug-22 5:17 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Aug-22 | Option Exercise | 1,773 | -- | -- | 3% 59.89K to 61.66K | |
| 19-Aug-22 5:17 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Aug-22 | Option Sale | 532 | $14.96 | $7,959.73 | (< 1%) 61.66K to 61.13K | |
| 11-Jan-22 4:42 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 07-Jan-22 | Option Exercise | 57,657 | $7.54 | $434,832.00 | 2581% 2.23K to 59.89K | |
| 03-Nov-21 5:00 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 01-Nov-21 | Market Sale (Planned) | 6,000 | $18.07 | $108,424.00 | (73%) 8.23K to 2.23K | (< 1%) |
| 04-Aug-21 7:55 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 02-Aug-21 | Market Sale (Planned) | 6,000 | $20.52 | $123,134.00 | (42%) 14.23K to 8.23K | (< 1%) |
| 03-Jun-21 6:26 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 02-Jun-21 | Market Sale (Planned) | 8,200 | $26.43 | $216,696.00 | (37%) 22.43K to 14.23K | (< 1%) |
| 03-Jun-21 6:26 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 01-Jun-21 | Market Sale (Planned) | 25,800 | $26.81 | $691,665.00 | (53%) 48.23K to 22.43K | < 1% |
| 06-May-21 8:03 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 03-May-21 | Option Exercise | 6,000 | $10.21 | $61,260.00 | 11% 54.23K to 60.23K | |
| 06-May-21 8:03 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 03-May-21 | Market Option Sale (Planned) | 6,000 | $24.84 | $149,051.00 | (10%) 60.23K to 54.23K | |
| 25-Feb-21 8:22 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 23-Feb-21 | Market Sale (Planned) | 31,000 | $33.60 | $1,041,640.00 | (36%) 85.23K to 54.23K | (3%) |
| 08-Feb-21 9:33 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 07-Feb-21 | Grant | 12,500 | -- | -- | 17% 72.73K to 85.23K | |
| 04-Nov-20 5:03 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 02-Nov-20 | Market Sale (Planned) | 6,000 | $17.14 | $102,812.00 | (8%) 78.73K to 72.73K | (2%) |
| 22-Oct-20 5:34 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 21-Oct-20 | Market Sale (Planned) | 9,007 | $18.31 | $164,928.00 | (10%) 87.74K to 78.73K | 4% |
| 22-Oct-20 5:34 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 20-Oct-20 | Market Sale (Planned) | 7,900 | $17.48 | $138,090.00 | (8%) 95.64K to 87.74K | (< 1%) |
| 20-Oct-20 2:11 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 16-Oct-20 | Market Sale (Planned) | 993 | $17.00 | $16,881.00 | (1%) 96.63K to 95.64K | (3%) |
| 07-Feb-20 5:17 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 05-Feb-20 | Market Sale (Planned) | 100 | $17.11 | $1,711.00 | (< 1%) 96.73K to 96.63K | (2%) |
| 24-Jul-19 5:52 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 23-Jul-19 | Market Sale (Planned) | 1,900 | $18.65 | $35,439.00 | (2%) 98.63K to 96.73K | 6% |
| 24-Jul-19 5:52 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 22-Jul-19 | Market Sale (Planned) | 1,400 | $18.57 | $26,004.00 | (1%) 100.03K to 98.63K | 6% |
| 18-Apr-19 6:30 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 17-Apr-19 | Market Sale (Planned) | 4,000 | $24.92 | $99,666.30 | (4%) 104.03K to 100.03K | 30% |
| 18-Jan-19 5:42 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 16-Jan-19 | Market Sale (Planned) | 4,000 | $19.55 | $78,209.90 | (4%) 108.03K to 104.03K | 10% |
| 20-Sep-18 7:33 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 18-Sep-18 | Grant | 12,500 | -- | -- | 13% 98.03K to 110.53K | |
| 20-Sep-18 7:33 PM View: | Kalvista Pharmaceuticals, I... (KALV) | 18-Sep-18 | Payment of Exercise | 2,500 | $17.05 | $42,625.00 | (2%) 110.53K to 108.03K | (3%) |